|
|
Volumn 7, Issue 12, 1994, Pages 2179-2184
|
|
High-dose inhaled steroids in asthmatics: Moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis
a
|
|
Author keywords
Asthma; Beclomethasone dipropionate; Drug treatment; Fluticasone propionate; Inhaled corticosteroids
|
|
Indexed keywords
BECLOMETASONE DIPROPIONATE;
CORTICOSTEROID;
FLUTICASONE PROPIONATE;
ADULT;
AGED;
ARTICLE;
ASTHMA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERANCE;
FEMALE;
HUMAN;
HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM;
INHALATIONAL DRUG ADMINISTRATION;
LUNG FUNCTION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PEAK EXPIRATORY FLOW;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ADMINISTRATION, INHALATION;
ADMINISTRATION, TOPICAL;
ANDROSTADIENES;
ANTI-INFLAMMATORY AGENTS;
ASTHMA;
BECLOMETHASONE;
DEPRESSION, CHEMICAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
FEMALE;
FORCED EXPIRATORY VOLUME;
GLUCOCORTICOIDS;
HUMANS;
HYPOTHALAMO-HYPOPHYSEAL SYSTEM;
MALE;
MIDDLE AGED;
PEAK EXPIRATORY FLOW RATE;
PITUITARY-ADRENAL SYSTEM;
VITAL CAPACITY;
|
|
EID: 0028576801
PISSN: 09031936
EISSN: None
Source Type: Journal
DOI: 10.1183/09031936.94.07122179 Document Type: Article |
|
Times cited : (67)
|
|
References (0)
|
